Cargando…
Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine
Autores principales: | Rogawski McQuade, Elizabeth T, Breskin, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409898/ https://www.ncbi.nlm.nih.gov/pubmed/34480860 http://dx.doi.org/10.1016/S0140-6736(21)01817-1 |
Ejemplares similares
-
Notice of addendum to Article reporting Oxford trial of ChAdOx1 nCoV-19 vaccine
por: Pollard, Andrew J
Publicado: (2020) -
Inflammatory myositis after ChAdOx1 vaccination
por: Maramattom, Boby Varkey, et al.
Publicado: (2021) -
Postvaccinal Encephalitis after ChAdOx1 nCov‐19
por: Zuhorn, Frédéric, et al.
Publicado: (2021) -
The conundrum of two-dose interval of ChAdOx1 nCOV-19 corona virus vaccine: Way ahead
por: Bobdey, Saurabh, et al.
Publicado: (2021) -
Heterologous ChAdOx1-nCoV19–BNT162b2 vaccination provides superior immunogenicity against COVID-19
por: Richardson, Christopher D
Publicado: (2021)